InduPro
Ben Setter is a Principal Scientist at InduPro since October 2022, with prior experience as a Senior Scientist at Silverback Therapeutics from September 2016 to July 2022, focusing on purification and characterization of antibodies, antigens, ADCs, and various proteins. Ben Setter's experience includes developing and optimizing downstream processes at Emergent BioSolutions, where roles spanned from June 2007 to April 2016, including responsibilities for GMP transfer and manufacturing. Ben Setter began a career as a Manufacturing Associate at ICOS from June 2005 to June 2007. Academic credentials include a Bachelor of Science in Biology from the University of Washington.
InduPro
InduPro is bringing life-changing therapies to patients through novel cell-surface platform technologies. We are defining and manipulating protein interactions beyond natural signaling paradigms. InduPro platforms, integrate inherent protein proximity at the cell surface with the ability to manipulate protein pairings via induced protein proximity to create novel signaling pathways and logic gates.